S&P Futures

7,445.25

+43.25

+0.58%

Dow Futures

51,880.00

+495.00

+0.96%

Nasdaq Futures

27,207.50

+122.25

+0.45%

Russell 2000 Futures

2,795.30

+34.80

+1.26%

10-Yr Bond

4.8590

+0.0220

+0.45%

VIX

23.46

-2.18

-8.50%

Gold

4,117.20

+42.30

+1.04%

Bitcoin USD

74,561.26

-1,307.06

-1.72%

Crude Oil Dec 26

88.31

-2.52

-2.77%

US Private Equity

10,772.76

+11.83

+0.11%

HKSE - Delayed Quote HKD

AIM Vaccine Co., Ltd. (6660.HK)

1.520 -0.040 (-2.56%)

At close: November 6 at 2:51:22 PM GMT+8

Loading Chart for 6660.HK

Chart Range Bar

Interval:

In partnership with ChartIQ

AIM Vaccine's 20-Valent Pneumococcal Conjugate Vaccine Receives Clinical Approval, Upgraded Iterative Major Product Expected to Seize Domestic Opportunities

World's First Serum-Free Iterative Rabies Vaccine from AIM Successfully Passes On-Site Registration Inspections and Is Imminent for Launch

Global Penny Stocks To Watch In January 2026

Mobilize your Website

View Site in Mobile | Classic

Share by:

U.S. markets open in 2h 6m

AIM Vaccine Co., Ltd. (6660.HK)

Recent News

AIM Vaccine's 20-Valent Pneumococcal Conjugate Vaccine Receives Clinical Approval, Upgraded Iterative Major Product Expected to Seize Domestic Opportunities

World's First Serum-Free Iterative Rabies Vaccine from AIM Successfully Passes On-Site Registration Inspections and Is Imminent for Launch

Global Penny Stocks To Watch In January 2026

Related Tickers